Rivastigmine 24HR Patches

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

DLA TROOP SUPPORT

Contract Value

Not provided

Codes & Classification
Solicitation Number

SPE2D221R0113

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Classification Code

6505

Additional Details
Set Aside

None

Place of Performance

Saint Albans, Vermont, UNITED STATES

SourceSAM
The Defense Logistics Agency (DLA) Troop Support has issued an award notice for the procurement of Rivastigmine 24-hour patches, under contract SPE2D222D0147. This contract supports the ongoing supply of pharmaceutical products, specifically Rivastigmine patches, which are commonly used in the management of dementia associated with Alzheimer’s and Parkinson’s diseases. The place of performance for this contract is Saint Albans, Vermont, United States. The scope of this procurement encompasses the manufacturing and delivery of Rivastigmine 24HR patches, aligning with NAICS code 325412 (Pharmaceutical Preparation Manufacturing) and Product Service Code 6505 (Drugs and Biologicals). The contract is structured with option years to ensure continuity of supply; recent modifications have invoked Option Year 1 (covering September 14, 2023, through September 13, 2024) and Option Year 2 (covering September 14, 2024, through September 13, 2025). These extensions reflect the government’s intent to maintain a reliable and secure supply chain for this critical pharmaceutical product. Key requirements and objectives of the contract include compliance with federal supply chain security mandates. Notably, the contract has been modified to incorporate the Drug Supply Chain Security Act (DSCSA), ensuring traceability and integrity of the pharmaceutical supply chain. Additionally, Federal Acquisition Regulation (FAR) clause 52.204-27, which prohibits the use of certain covered applications (such as those by ByteDance), and clause 52.204-30, related to the Federal Acquisition Supply Chain Security Act Orders, have been added to reinforce supply chain security and compliance with federal regulations. The contracting activity is managed by DLA Troop Support, a federal office responsible for ensuring the armed forces and other federal entities have access to essential medical supplies. The primary point of contact for this procurement is Phyllis Daraio, who can be reached at [email protected] or by phone at 215-737-7941. This procurement is classified as an award notice and remains active as of the posting date, August 14, 2024. Contractors interested in this opportunity should note the emphasis on supply chain security, regulatory compliance, and the requirement for consistent, high-quality pharmaceutical manufacturing capabilities. The contract documentation and further details are available through the official SAM.gov listing (Opportunity ID: a698f0c810ca42efb26f9b0af94e960e). Overall, this contract represents a sustained federal commitment to secure, compliant, and reliable pharmaceutical supply for critical medical needs, with a focus on long-term vendor relationships and adherence to evolving federal security requirements.
Documents6